By Ashok Punatar Mob: 09820746494 Email: email@example.com
Dr. Lal PathLabs Limited (“Company” or “Issuer”) proposes to open on December 8, 2015, an Initial Public Offering of up to 11,600,000 equity shares of Face Value of Rs. 10 Each (“Equity Shares”) for cash at a Price Band from Rs. 540 to Rs. 550 per Equity Share (the “Offer”) through an offer for sale of up to 1,261,996 Equity Shares by (Hony.) Brig. Dr. Arvind Lal; up to 2,056,747 Equity Shares by Dr. Vandana Lal; up to 238,226 Equity Shares by Eskay House (HUF), up to 550,386 Equity Shares by Mr. Anjaneya Lal (collectively, the “Promoter Selling Shareholders”) up to 5,860,000 Equity Shares by Wagner Limited; up to 1,471,575 Equity Shares by WestBridge Crossover Fund, LLC; up to 161,070 Equity Shares by Sanjeevini Investment Holdings (collectively, the “Investor Selling Shareholders” and with the Promoter Selling Shareholders, the “Selling Shareholders”) (the “Offer For Sale”). The Offer shall constitute up to 14.04% of the post-Offer paid-up Equity Share Capital of the Company. The Company and the Selling Shareholders may, in consultation with the Book Running Lead Managers (“BRLMs”), offer a discount of up to Rs.15 on the Offer Price to Retail Individual Bidders.